Zoncare VIS Patient Monitor Wins The iF DESIGN AWARD 2022


Zoncare VIS patient monitor has been announced as the winner of the iF DESIGN AWARD 2022, chosen for the coveted seal of excellence out of nearly 11,000 entries from the participants in 57 nations. Zoncare VIS monitor focuses on the design of customer concerns to satisfy the pain points and needs of medical staff, such as simplicity of operation, practical function, parameter accuracy and human-computer interaction, so they can use it more handy and more comfortable.




As one of the domestic medical equipment manufacturers in China that has been recognized by international authorities in the field of industrial design, this honor is the result of the collaboration during the product development process. Zoncare commits to the exploration, innovation, and development of medical equipment industry. To be the main power to protect the health of human being.


About the iF Design Award

The iF DESIGN AWARD is one of the world’s most prestigious design awards. Organized in Germany since 1953, the iF seal signifies good design, for consumers and the design community.


Zoncare Design Award List

In 2016     Red Dot Design Award(iMAC 12

In 2022     iF Design Award(VIS patient monitor)




About Zoncare

Established in 2005, Zoncare concentrates on clinical medical equipment development and production. During the 17 years development, Zoncare has yielded substantial results in Medical Equipment Core technology research. At present, Zoncare has obtained more than 100 product technical patents and proprietary intellectual property rights.


Based on the domestic and focus on the global market, Zoncare intends to reach further missions. So far, Zoncare global service system has come into shape. Established 27 branches offices domestically, and local marketing agents in the 5 continents globally. Zoncare is providing fast and professional pre-sales, sales, and after-sales service to more than 50,000 medical users from over 100 countries.



修改浏览器滑块样式: 4px,4px,#f00



您可以查看其他栏目或返回 首页